Skip to main content
2024 Guide to Patient Support Services

Organon

2024 PSS Guide

The Organon Access Program

Organon offers The Organon Access Program to assist patients who have been prescribed Ontruzant (Table).

The Organon Access Program

The Organon Access Program can assist with benefit investigation, prior authorizations, the appeal process, and offers the Organon Co-pay Assistance Program as well as the Organon Patient Assistance Program.

The Organon Co-pay Assistance Program

Once enrolled, eligible, privately insured patients pay the first $5 of their copay per infusion. The maximum copay assistance program benefit is $25,000 per patient, per calendar year.

The Organon Patient Assistance Program

The Organon Patient Assistance Program is primarily designed to help those who do not have insurance coverage; however, if your patient has insurance coverage for Ontruzant, including Medicare Part D, but still has trouble paying for their medicine, they may request that an exception be made, provided their income is not above a set limit and they meet certain other medical and/or insurance criteria.

For more information on The Organon Patient Assistance Program, visit Organon Patient Assistance Program or call 888-727-0015.

TABLE Organon Oncology Drug

Drug
Indication
Patient support programs

Drug
Ontruzant (trastuzumab-dttb)
Indication
The treatment of HER2-overexpressing breast cancer; treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma
Patient support programs